Articles On Medibio (ASX:MEB)

Small caps have closed lower today, but they finished the week in the green for a second week in a row. The Small Ordinaries index dropped 16.9 points, or 0.5 per cent, on Friday, doing slightly better than their larger peers. The ASX100 fi...

Source: PopTika, Shutterstock Summary Medibio Limited and Compass Group have signed the first Statement of Works (SOW) agreement to start the implementation of ilumen, a mental health software, in the UK. The two parties had earlier...

Source:domturner, Shutterstock Summary Blue Energy has executed a non-binding Heads of Agreement with Origin Energy, leading to a surge of 27.6 per cent in its share price. Medibio has signed the first Statement of Works agreement wit...

ShareCafeAustralia…One Hour In…ASX200 down 69 points ASX200 down 69 points (1%) to 6676.   Afterpay (-2.8%) / Splitit (-3.2%) / Zip Co (-3.3%); press speculation  that the “RBA will move on the BNPL later sector to force industry players t...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

US stocks dip as Treasury yields spike US stocks dipped from record highs on Thursday trading in the US, as US treasury yields spiked. The 10-year benchmark yield surged to 1.73%, rising from 1.68% yesterday. Despite the signal the Fed is s...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

2021 is set to be another big year for ASX capital raisings with solid volumes so far in 2021. In the first nine weeks of the new year, ASX companies have raised over $1.96 billion. Although this is lower than the $3 billion raised in the f...

Source: ShutterstockProfessional Summary Biotech penny stocks are extremely volatile, given the unpredictable nature of the biotechnology industry. Positive clinical developments and regulatory approvals for biotech penny players coul...

Small caps bounced back solidly from yesterday’s losses with the Small Ordinaries index finished Tuesday up 1.58 per cent to 3,123.7. The ASX 200 rose by 1.19 per cent to 6,742.6 however the Emerging Companies nano-cap index only rose by 0....

Summary The Australian benchmark equity index ASX 200 is trading higher over 1 per cent even as global markets remained muted in the overnight session. While ASX 200 Industrials (Sector) was up 1.78 per cent, ASX 200 Consumer Discretio...

Summary Medibio Limited disclosed that its sleep staging software, MEBsleep, has obtained CE Mark approval. With the CE Mark, the health technology player can accelerate MEBsleep commercialisation activities in the EEC. The Company is...

Medibio (ASX:MEB) has announced it has received CE Mark approval for its sleep staging software, MEBsleep.

Summary Mental health technology company Medibio commences initial phase of testing for its consumer mental health app. Medibio consumer mental health app has unique biometric functionality. The Company aims to address the increased n...

Summary Medibio (ASX:MEB) announced that US FDA needs a larger sample of clinical data for it to be considered substantially equivalent in relation to its 510(k) application for MEBsleep. FDA has invited Medibio so as to discuss the ad...

Summary With Australia’s economy on rebound, negative sentiments among investors appears to reduce, providing push to stocks with upside potential. Several ASX-listed small caps are posting decent growth in the revenue. Consequently,...

ShareCafeHidden Gems Webinar Recap – APH, K2F, MEB, ICT   Catch up on the full webinar with presentations from Australian Primary Hemp (ASX: APH), K2Fly Limited (ASX: K2F), Icollege Limited (ASX: ICT) and Medibio Limited (ASX: MEB). Hidden...

ShareCafeMedibio Limited (ASX: MEB) – Hidden Gems Webinar Presentation   Presenter – Claude Solitario – Managing Director – Medibio is a health technology company pioneering the use of objective measures to aid in the early detection and s...

Mental health stocks set to benefit from increased mental health awareness This week’s budget included measures to help patients and the sector Cogstate (ASX:CGS) is 2020’s biggest winner so far up over 50 per cent As the world becomes i...

Medibio (ASX:MEB), a mental health technology company pioneering the use of objective measures to aid in the early detection and screening of certain mental health conditions, has announced a new Clinical Trial Agreement with MedBri...

A quick wrap of the ASX’s key winners and losers on Monday, August 3. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 558 stocks rose, 762 declined and 78...

A quick wrap of the ASX’s key winners and losers on Monday, July 27. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 722 stocks rose, 625 declined and 755...

A quick wrap of the key winners and losers on Monday, June 15. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. The ASX had a modest start but tumbled in the las...

A quick wrap of the key winners and losers on Friday, June 12. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today the ASX plunged over 3 per cent in the firs...

A quick wrap of the key winners and losers on Tuesday, May 26. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Company Price % Change Volume...

Cellular medicine company Mesoblast Limited (ASX:MSB) has moved onto phase two (out of three) for its COVID-19 treatment, after getting promising initial results on US patients with moderate to severe symptoms. The company wants to find out...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Viagra mouth spray maker SUDA Pharmaceuticals (ASX:SUD) has talked a multi-billion dollar pharmaceutical company into backing its tech. Sanofi-Aventis has signed a feasibility agreement to test the mouth spray technology with one of its own...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Health technology company MediBio (ASX: MEB) has completed the first of four planned pilot programs using its ilumen corporate health and wellbeing product, with the assistance of employees from UK-based food service company Compass Group....

Australian health care sector is growing potentially by generating significant profits in a short period, and that is something the investors are also closely monitoring. Australia’s public healthcare system is one of the world’s best, join...

Here’s our fortnightly wrap of all the news driving ASX small cap health stocks. We last checked in with ASX small cap health stocks just hours after Opthea’s (ASX:OPT) anti macular degeneration drug passed a large clinical test with flying...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

On 29 July 2019, post the closure of the trading session, the Australian Benchmark index S&P/ASX 200 index was at 6825.8, which is ~0.5% above the previous close. Let’s look at the latest updates on the six stocks belonging to different...

Health technology company Medibio Limited (ASX: MEB) has announced it will join forces with digital corporate wellness developer WellteQ to provide industry with a robust employee health solution which integrates mental well-being. The comp...

Medibio (ASX: MEB) has gained 24 per cent this morning after announcing an integration partnership with digital corporate wellness solution WellteQ. Medibio’s “ilumen” digital mental well-being assessment will be integrated into WellteQ’s s...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

Medical technology company Medibio Ltd [ASX:MEB] has seen a massive spike in their share price within the morning hours of trading. Shares were up 116.67% earlier today, reaching 2.6 cents apiece. The surge is likely a result of… The post M...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken as at 10:15am, once every stock has commenced trading. Stocks highlighted in...

At Stockhead we are as amazed as our readers when stocks rise by over 100 per cent in a day. But its a more common occurrence than we thought. There have been 23 stocks that have achieved that feat. The three most common reasons are success...

Health technology company Medibio (ASX: MEB) has taken an assertive step towards commercialising its corporate health product called ‘ilumen’ after signing a commercial agreement with UK company Compass Group to begin the first of two pilot...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...